The effect of anthracycline-based chemotherapy on endothelial function and arterial stiffness in breast cancer patients

被引:0
|
作者
Anastasiou, M. [1 ]
Oikonomou, E. [2 ]
Theofilis, P. [3 ]
Papamikroulis, G. A. [2 ]
Gazouli, M. [4 ]
Pesiridis, T. [2 ]
Goliopoulou, A. [2 ]
Papatheodoridi, D. [5 ]
Psyrri, A. [1 ]
Zagouri, F. [5 ]
Siasos, G. [2 ]
Tousoulis, D. [3 ]
机构
[1] Attikon Univ Hosp, Athens, Greece
[2] Sotiria Reg Chest Dis Hosp, Dept Cardiol 3, Athens, Greece
[3] Hippokrateion Hosp, Athens, Greece
[4] Univ Athens, Sch Med, Athens, Greece
[5] Alexandra Univ Hosp, Athens, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: A narrative review
    Simoes, Ricardo
    Silva, Luciana Maria
    Valle Mussi Cruz, Andre Luiz
    Fraga, Vanessa Gomes
    Sabino, Adriano de Paula
    Gomes, Karina Braga
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 989 - 996
  • [32] Longitudinal rotation: a new way to detect the cardiotoxicity of anthracycline-based chemotherapy in breast cancer patients
    Huang, Jun
    Yan, Zi-Ning
    Rui, Yi-Fei
    Shen, Dan
    Fan, Li
    Chen, Dong-Liang
    ONCOTARGET, 2017, 8 (41) : 70072 - 70083
  • [33] Late cardiotoxicity in patients with breast cancer after taxane/anthracycline-based neoadjuvant and adjuvant chemotherapy
    Koroleva, I.
    Kopp, M. V.
    Kasulin, A. N.
    Kucheryavyy, J. A.
    Byakhov, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Effect of primary anthracycline-based chemotherapy on disseminated tumor cells in locally advanced breast cancer
    Jäger, C
    Kafka, A
    Bossert, S
    Grundmann, R
    Windisch, J
    Kreienberg, R
    Heilmann, V
    ANTICANCER RESEARCH, 2004, 24 (5B) : 3209 - 3214
  • [35] Time-Dependent Effect of Anthracycline-Based Chemotherapy on Central Arterial Stiffness: A Systematic Review and Meta-Analysis
    Schneider, Caroline
    Gonzalez-Jaramillo, Nathalia
    Marcin, Thimo
    Campbell, Kristin L.
    Suter, Thomas
    Bano, Arjola
    Wilhelm, Matthias
    Eser, Prisca
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [36] Neutrophil count is not associated with infection episodes in breast cancer patients treated with anthracycline-based chemotherapy
    Mendonca, M. A. O.
    Pereira, A. H. M.
    Silva, S. R.
    Mardegan, M. C.
    Murta, E. F. C.
    Tavares-Murta, B. M.
    EUROPEAN JOURNAL OF CANCER CARE, 2009, 18 (02) : 184 - 190
  • [37] Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy
    El-Sherbeny, Wafaa S.
    Sabry, Nesreen M.
    Sharbay, Radwa M.
    JOURNAL OF ECHOCARDIOGRAPHY, 2019, 17 (02) : 76 - 83
  • [38] Clinical and echocardiographic characteristics of female patients with breast cancer treated with anthracycline-based combined chemotherapy
    Spannbauer, A.
    Han, E.
    Gramser, A.
    Gyoengyoesi, M.
    Bergler-Klein, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 2) : 196 - 197
  • [39] Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients
    Isabel Chirivella
    Begoña Bermejo
    Amelia Insa
    Alejandro Pérez-Fidalgo
    Ana Magro
    Susana Rosello
    Elisa García-Garre
    Paloma Martín
    Ana Bosch
    Ana Lluch
    Breast Cancer Research and Treatment, 2009, 114 : 479 - 484
  • [40] Effective Antiemetic Therapy Is Important With Adjuvant Anthracycline-based Chemotherapy in Breast Cancer
    Takala, Laura
    Barlund, Maarit
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Pirkko, Liisa
    ANTICANCER RESEARCH, 2019, 39 (01) : 279 - 283